The Swiss drugmaker expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.
Source link
Roche Forecasts 2026 Growth, Cites Drug-Pipeline Strength
Date:
More like thisRelated
2026 MLB trade deadline grades: Report cards for every deal
Bradford DoolittleCloseBradford DoolittleESPN Staff WriterMLB writer and analyst for...
A Hong Kong democracy activist’s long-awaited London reunion may be cut short
HONG KONG -- After spending more than five years...
Big Companies Are Starting to Hire Again, Defying Predictions of AI Wipeout
After a year of holding back on new hires,...